Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events

Martin O’Donnell(Apple (Israel)), Andrew Mente(Population Health Research Institute), Sumathy Rangarajan(Population Health Research Institute), Matthew McQueen(Population Health Research Institute), Xingyu Wang(Hypertension Institute), Lisheng Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Hou(Community Health Center), Shun Fu Lee(Population Health Research Institute), Prem Mony(St. John's National Academy of Health Sciences), Anitha Devanath(St. John's National Academy of Health Sciences), Annika Rosengren(University of Gothenburg), Patricio López‐Jaramillo(Universidad De Santander), Rafael Díaz(Estudios Clínicos Latinoamérica), Álvaro Avezum(Instituto Dante Pazzanese de Cardiologia), Fernando Laņas(Universidad de La Frontera), Khalid Yusoff(UCSI University), Romaina Iqbal(Aga Khan University), Rafał Ilow(Wroclaw Medical University), Noushin Mohammadifard(Isfahan University of Medical Sciences), Sadi Güleç(Ankara University), Afzal Hussein Yusufali(Dubai Health Authority), Iolanthé M. Kruger(North-West University), Rita Yusuf(Independent University), Jephat Chifamba(University of Zimbabwe), Conrad Kabali(Population Health Research Institute), Gilles R. Dagenais(Lung Institute), Scott A. Lear(Providence Health Care), Koon Teo(Population Health Research Institute), Salim Yusuf(Population Health Research Institute)
New England Journal of Medicine
August 13, 2014
Cited by 893Open Access
Full Text

Abstract

BACKGROUND: The optimal range of sodium intake for cardiovascular health is controversial. METHODS: We obtained morning fasting urine samples from 101,945 persons in 17 countries and estimated 24-hour sodium and potassium excretion (used as a surrogate for intake). We examined the association between estimated urinary sodium and potassium excretion and the composite outcome of death and major cardiovascular events. RESULTS: The mean estimated sodium and potassium excretion was 4.93 g per day and 2.12 g per day, respectively. With a mean follow-up of 3.7 years, the composite outcome occurred in 3317 participants (3.3%). As compared with an estimated sodium excretion of 4.00 to 5.99 g per day (reference range), a higher estimated sodium excretion (≥ 7.00 g per day) was associated with an increased risk of the composite outcome (odds ratio, 1.15; 95% confidence interval [CI], 1.02 to 1.30), as well as increased risks of death and major cardiovascular events considered separately. The association between a high estimated sodium excretion and the composite outcome was strongest among participants with hypertension (P=0.02 for interaction), with an increased risk at an estimated sodium excretion of 6.00 g or more per day. As compared with the reference range, an estimated sodium excretion that was below 3.00 g per day was also associated with an increased risk of the composite outcome (odds ratio, 1.27; 95% CI, 1.12 to 1.44). As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a reduced risk of the composite outcome. CONCLUSIONS: In this study in which sodium intake was estimated on the basis of measured urinary excretion, an estimated sodium intake between 3 g per day and 6 g per day was associated with a lower risk of death and cardiovascular events than was either a higher or lower estimated level of intake. As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a lower risk of death and cardiovascular events. (Funded by the Population Health Research Institute and others.).


Related Papers

No related papers found

Powered by citation graph analysis